Journals / European Journal of Rheumatology / 2018 / Cilt: 5 - Sayı: 3

Symmetric polyarthritis as an initial symptom in granulomatosis with polyangiitis: A report of six cases and review of the literature

Pages
191–193
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Malesex, anti-cyclic citrulinated peptide negativity, and early arthritis period are important clues for GPA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Granulomatosis with polyangiitis (GPA) is a primary systemic vasculitis characterized by granuloma-tous inflammation.
📊
Key Findings & Data:Arthritis in GPA is most commonly associated with large joints, particularly theknees and ankles; however, symmetrical polyarthritis of small joints has been rarely reported in lit-erature.
💡
Conclusion & Impact:Malesex, anti-cyclic citrulinated peptide negativity, and early arthritis period are important clues for GPA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Granulomatosis with polyangiitis (GPA) is a primary systemic vasculitis characterized by granuloma-tous inflammation. Arthritis in GPA is most commonly associated with large joints, particularly theknees and ankles; however, symmetrical polyarthritis of small joints has been rarely reported in lit-erature. Here, we describe retrospective analysis of six patients with GPA showing initial symptom ofsymmetrical polyarthritis who were followed-up by three different rheumatology departments. Malesex, anti-cyclic citrulinated peptide negativity, and early arthritis period are important clues for GPA.

🔖

Cite This Article

ONAT, A. M., ÖNDER, M. E., KISACIK, B., SAYARLIOĞLU, M. (2022). Symmetric polyarthritis as an initial symptom in granulomatosis with polyangiitis: A report of six cases and review of the literature. European Journal of Rheumatology, Cilt: 5 - Sayı: 3, 191–193. https://ajindex.com/articles/511630

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. de Souza FH, Radu Halpern AS, Valente Barbas CS, Shinjo SK. Wegener’s granulomatosis: ex- perience from a Brazilian tertiary center. Clin Rheumatol 2010; 29: 855-60. [CrossRef ] Rodrigues CE, Callado MR, Nobre CA, Moura FE, Vieira RM, de Albuquerque LA, et al. Wegener’s granulomatosis: prevalence of the initial clinical manifestations-report of six cases and review of the literature. Rev Bras Reumatol 2010; 50: 150- 64. [CrossRef ] Weeda LW Jr, Coffey SA. Wegener’s granuloma- tosis. Oral Maxillofac Surg Clin North Am 2008; 20: 643-9. [CrossRef ] Olivencia-Simmons I. Wegener’s granulomato- sis: symptoms, diagnosis, and treatment. J Am Acad Nurse Pract 2007; 19: 315-20. [CrossRef ] Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98. [CrossRef ] Chinoy H, McKenna F. Wegener’s granulomato- sis and rheumatoid arthritis overlap. Rheuma- tology (Oxford) 2002; 41: 588-9. [CrossRef ] Kamali S, Polat NG, Kasapoglu E, Gul A, Ocal L, Aral O, et al. Anti-CCP and antikeratin antibod- ies in rheumatoid arthritis, primary Sjögren’s syndrome, and Wegener’s granulomatosis. Clin Rheumatol 2005; 24: 673-6. [CrossRef ]